Healthy volunteers help test simpler injection for mirikizumab

NCT ID NCT07446101

Recruiting now Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study in 450 healthy volunteers checks if a single injection of mirikizumab works as well as two separate shots. The main goal is to see how the body handles the drug and to ensure safety. Participants will be monitored for about 15 weeks with blood tests and check-ups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mirikizumab

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

Axis Clinicals LLC
RECRUITING

Dilworth, Minnesota, 56529, United States
Fortrea Clinical Research Unit
RECRUITING

Daytona Beach, Florida, 32117, United States
Fortrea Clinical Research Unit
RECRUITING

Dallas, Texas, 75247, United States
Fortrea Clinical Research Unit
RECRUITING

Madison, Wisconsin, 53704, United States
Worldwide Clinical Trials, Inc.
RECRUITING

San Antonio, Texas, 78217, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.